Nigam PK: Serum lipid profile: fasting or non-fasting? Indian J Clin Biochem 2011, 26 (1) : 96–97.Nigam, P. K. (2011). Serum lipid profile: Fasting or non-fasting. Indian Journal of Clinical Biochemistry, 26(1), 96-97.Nigam, P. K. (2011). Serum lipid profile: Fasting or ...
The measurement of non-fasting lipid profiles has several advantages: patients do not need to fast and clinicians can have the lipid profile determined at any random time of day. Non-HDL-C and apo B are good alternatives for LDL-C and are not influenced by the non-fasting state....
This study was designed to assess the effect of non-moderate and prolonged drinking on various lipid values. Fifty non-moderate drinkers (>25 g/day for last 10 years) were selected and lipid profile measurement was done at fasting state and findings were analyzed and the level was correlated ...
First, the correlation values between each of the variables mentioned above were calculated separately in the form of a matrix; then, based on the calculated correlation values, a coefficient was assigned to each variable, representing the different weights of each variable in determining the ...
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998; 27: 1213–1219. Article CAS Google Scholar Arun J, ...
p-values are derived from a hypergeometric test. (e) COBLL1 expression in subcutaneous adipose tissue before and after a very low caloric diet (VLCD, upper panel, n = 18), corresponding body weight (lower panel), Wilcoxon signed-rank test....
24 For this correction, we used nonfasting triglyceride values from 6709 individuals without lipid-lowering therapy attending both the baseline 1976-1978 examination and the 1991-1994 examination; however, the main analyses were conducted on 13 956 individuals. These 2 measurements were 15 years ...
In addition, to avoid the effects of lipid-lowering on all lipid parameters, 933 participants with lipid-lowering medication use were excluded. Furthermore, 1111 individuals with diabetes (defined using the 2015 American Diabetes Association (ADA) criteria [14] of a fasting plasma glucose ≥126 ...
Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and integrated the findings with expression and proteomic data. For NAFL, we utili
Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive and more susceptible to developing cirrhosis and hepatocellular carcinoma. Currentl